SEC Tracker
Get the app

PDS Biotechnology PDSB

Nant Capital reports a 19.9% stake in PDS Biotechnology

Form
Schedule 13D
Filed
Importance
Notable

Not explained yet; the original is on EDGAR.

Ownership stake disclosure by Nant Capital, LLC

View on EDGAR

Open in the app

Get an email when PDS Biotechnology files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Sutro Biopharma STRO public float $60M, Jun 30, 2025
  2. Medicinova MNOV public float $62M, Jun 30, 2025
  3. iBio IBIO public float $58M, Dec 31, 2025
  4. Lifevantage LFVN public float $64M, Dec 31, 2025
  5. Veru VERU public float $64M, Mar 31, 2025, over 18 months old